Ionis Pharmaceuticals Inc (IONS)
38.76
+0.37
(+0.96%)
USD |
NASDAQ |
Nov 01, 16:00
38.76
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Market Cap: 6.113B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 6.113B |
| October 31, 2024 | 6.055B |
| October 30, 2024 | 6.192B |
| October 29, 2024 | 6.263B |
| October 28, 2024 | 6.365B |
| October 25, 2024 | 6.181B |
| October 24, 2024 | 6.114B |
| October 23, 2024 | 6.059B |
| October 22, 2024 | 6.100B |
| October 21, 2024 | 6.151B |
| October 18, 2024 | 6.258B |
| October 17, 2024 | 6.070B |
| October 16, 2024 | 6.176B |
| October 15, 2024 | 5.968B |
| October 14, 2024 | 6.092B |
| October 11, 2024 | 6.062B |
| October 10, 2024 | 5.985B |
| October 09, 2024 | 6.002B |
| October 08, 2024 | 5.961B |
| October 07, 2024 | 5.971B |
| October 04, 2024 | 5.979B |
| October 03, 2024 | 5.963B |
| October 02, 2024 | 6.211B |
| October 01, 2024 | 6.162B |
| September 30, 2024 | 6.318B |
| Date | Value |
|---|---|
| September 27, 2024 | 6.442B |
| September 26, 2024 | 6.482B |
| September 25, 2024 | 6.465B |
| September 24, 2024 | 6.466B |
| September 23, 2024 | 6.597B |
| September 20, 2024 | 6.744B |
| September 19, 2024 | 6.741B |
| September 18, 2024 | 6.681B |
| September 17, 2024 | 6.547B |
| September 16, 2024 | 6.419B |
| September 13, 2024 | 6.654B |
| September 12, 2024 | 6.469B |
| September 11, 2024 | 6.707B |
| September 10, 2024 | 6.198B |
| September 09, 2024 | 7.066B |
| September 06, 2024 | 6.856B |
| September 05, 2024 | 7.040B |
| September 04, 2024 | 6.967B |
| September 03, 2024 | 6.917B |
| August 30, 2024 | 6.971B |
| August 29, 2024 | 7.296B |
| August 28, 2024 | 7.201B |
| August 27, 2024 | 7.069B |
| August 26, 2024 | 6.843B |
| August 23, 2024 | 6.860B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.616B
Minimum
Dec 01 2021
9.181B
Maximum
Dec 16 2019
6.319B
Average
6.151B
Median
Market Cap Benchmarks
| Biogen Inc | 25.32B |
| Alnylam Pharmaceuticals Inc | 35.33B |
| Biomarin Pharmaceutical Inc | 12.69B |
| Rigel Pharmaceuticals Inc | 249.85M |
| Apellis Pharmaceuticals Inc | 3.407B |
Market Cap Related Metrics
| PS Ratio | 6.890 |
| PEG Ratio | -0.9536 |
| Price to Book Value | 23.18 |
| Price | 38.76 |
| Earnings Yield | -6.50% |
| PEGY Ratio | -0.9536 |